Rankings
▼
Calendar
HRTX Q4 2020 Earnings — Heron Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
HRTX
Heron Therapeutics, Inc.
$153M
Q4 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$21M
-41.3% YoY
Gross Profit
$11M
54.4% margin
Operating Income
-$61M
-297.5% margin
Net Income
-$62M
-302.3% margin
EPS (Diluted)
$-0.68
QoQ Revenue Growth
+3.2%
Cash Flow
Operating Cash Flow
-$53M
Free Cash Flow
-$55M
Stock-Based Comp.
$16M
Balance Sheet
Total Assets
$354M
Total Liabilities
$117M
Stockholders' Equity
$236M
Cash & Equivalents
$105M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$21M
$35M
-41.3%
Gross Profit
$11M
$19M
-41.6%
Operating Income
-$61M
-$59M
-3.3%
Net Income
-$62M
-$58M
-7.5%
Revenue Segments
C I N V A N T I
$20M
98%
S U S T O L
$400,000
2%
← FY 2020
All Quarters
Q1 2021 →